References
- McDori R, Autilio-Gambetti L, Monaco S, Gambetti P. Experimental diabetic neuropathy: Impairment of slow transport with changes in axon cross-sectional area. Proc Natl Acad Sci USA 1985; 82: 7716–20
- Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4400 patients between 1947–1973. Diabetes Care 1978; 1: 252–63, 168–88
- Boulton AJM, Worth RC, Drury J, Hardisty CA, Wolf E, Cudworth AG, Ward JD. Genetic and metabolic studies in diabetic neuropathy. Diabetologia 1984; 26: 15–9
- Young RJ, Macintyre CCA, Martyn CN, Prescott RJ, Ewing DJ, Smith AF, Viberti G, Clarke BF. Progression of subclinical polyneuropathy in young patients with Type I (insulin-dependent) diabetes: associations with glycemic control and microangiopathy (microvascular complications). Diabetologia 1986; 29: 156–61
- Service FJ, Rizza RA, Daube JR, O'Brien PC, Dyck PJ. Near normoglycemia improved nerve conduction and vibration sensation in diabetic neuropathy. Diabetologia 1985; 28: 722–27
- McLaren EH, Burden AC, Moorhead PJ. Acety-lator phenotype in diabetic neuropathy. Br Med J 1977; 1: 291–3
- Bodansky HJ, Drury PL, Cudworth AG, Price Evans DA. Acetylator phenotypes and Type I (insulin-dependent) diabetics and microvascular disease. Diabetes 1981; 30: 907–10
- Shenfield GM, McCann VJ, Tjokresctio R. Acetylator status and diabetic neuropathy. Diabetologia 1982; 22: 441–4
- Bodansky HJ, Wolf E, Cudworth AG, Dean BM, Nineham LJ, Bottazzo GF, Matthews JA, Kurtz AB, Kohner EM. Genetic and immunological factors in microvascular disease in Type I (insulin-dependent) diabetes. Diabetes 1982; 31: 70–4
- Dornan TL, Ting A, McPherson CK, Peckar CO, Mann JI, Turner JC, Morris PJ. Genetic susceptibility to the development of retinopathy in insulin-dependent diabetes. Diabetes 1982; 31: 226–31
- Scheinin T, Groop L, Teir H, Koskimies S, Kontiainen S. HLA-types and insulin responses in insulin dependent diabetics with or without prolif-crative retinopathy. J Clin Lab Immunol 1985; 18: 17–20
- Dean BM, Becker F, McNally JM, Tarn AC, Schwartz G, Gale EAM, Bottazzo GF. Insulin autoantibodies in the pre-diabetic period: Correlation with islet cell antibodies and development of diabetes. Diabetologia 1986; 29: 339–42
- Bruining GJ, Molenaar J, Tuk CW, Lindeman J, Bruining HA, Marner B. Clinical time-course and characteristics of islet cell cytoplasmic antibodies in childhood diabetes. Diabetologia 1984; 26: 24–9
- Heding LG, Marshall MO, Persson B, Dahlquist G, Thalme B, Lindgren F, Akerblom HK, Rilva A, Knip M, Ludvigsson J, Stenhammar L, Strömberg L, Sövik O, Baevre H, Wefring K, Vidnes J, Kjaergärd JJ, Bro P, Kaad PH. Immunogenicity of monocomponent human and porcine insulin in newly diagnosed type I (insulin-dependent) diabetic children. Diabetologia 1984; 27: 96–8
- Heding LG. Radioimmunological determination of human C-peptide in serum. Diabetologia 1975; 11: 541–8
- Amos DB. Cytotoxicity testing in NIAID manual of tissue typing techniques. Department of Health. Education and Welfare, AtlantaUSA 1972; 42, Publ, no (NH) 80–545., p
- Kurtz AB, Matthews JA, Nabarro JDN. Insulin binding antibody: Reaction differences with bovine and porcine insulins. Diabetologia 1978; 15: 19–22
- Scheinin T, Groop L, Nikkilä E, Kontiainen S. Proliferative responses to insulin antigens in diabetics and controls. J Clin Lab Immunol 1983; 11: 135–41
- Wolf E, Spencer KM, Cudworth AG. The genetic susceptibility to type I (insulin-dependent) diabetes: Analysis of the HLA-DR association. Diabetologia 1983; 24: 224–30
- Schernthaner G, Mayr WR. Clinical and immunologic studies of HLA-DR typed insulin-dependent diabetics—a mini-review. Exp Clin Endocrinol 1984; 83: 184–91
- Ludvigsson J, Samuelson U, Beauforts C, Deschamps J, Dorchy H, Drash A, Francois R, Nerz G, New M, Schober E. HLA-DR3 is associated with a more slowly progressive form of type I (insulin-dependent) diabetes. Diabetologia 1986; 29: 207–10
- Groop LC, Teir H, Koskimies S, Groop P-H, Matikainen E, Verkkala E, Scheinin T, Kontiainen S, Teppo A-M, Tolppanen E-M, Tallgren LG. Risk factors and markers associated with proliferative retinopathy in patients with insulin-dependent diabetes. Diabetes 1986; 35: 1397–403
- Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984; 102: 520–6
- Testa MA, Puklin JE, Sherwin RS, Simonson DC. Clinical predictors of retinopathy and its progression in patients with type I diabetes during CSH or conventional insulin treatment. Diabetes 1985; 34(Suppl. 3)61–8